Scher HI - Search Results

1

Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer.

Schonhoft JD, Zhao JL, Jendrisak A, Carbone EA, Barnett ES, Hullings MA, Gill A, Sutton R, Lee J, Dago AE, Landers M, Bakhoum SF, Wang Y, Gonen M, Dittamore R, Scher HI. Schonhoft JD, et al. Among authors: scher hi. Cancer Res. 2020 Nov 15;80(22):4892-4903. doi: 10.1158/0008-5472.CAN-20-1216. Epub 2020 Aug 19. Cancer Res. 2020. PMID: 32816908 Free PMC article.

2

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy.

Zelefsky MJ, Scher HI, Krol G, Portenoy RK, Leibel SA, Fuks ZY. Zelefsky MJ, et al. Among authors: scher hi. Cancer. 1992 Nov 1;70(9):2319-25. doi: 10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820700918>3.0.co;2-8. Cancer. 1992. PMID: 1394060

3

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Among authors: scher hi. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

4

Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapy.

Petrylak DP, Scher HI, Li Z, Myers CE, Geller NL. Petrylak DP, et al. Among authors: scher hi. Cancer. 1992 Dec 15;70(12):2870-8. doi: 10.1002/1097-0142(19921215)70:12<2870::aid-cncr2820701225>3.0.co;2-f. Cancer. 1992. PMID: 1451069

5

Use of adaptive control with feedback to individualize suramin dosing.

Scher HI, Jodrell DI, Iversen JM, Curley T, Tong W, Egorin MJ, Forrest A. Scher HI, et al. Cancer Res. 1992 Jan 1;52(1):64-70. Cancer Res. 1992. PMID: 1727387

6

Introduction: prostate cancer.

Scher HI. Scher HI. Semin Oncol. 1994 Oct;21(5):511-3. Semin Oncol. 1994. PMID: 7939744 No abstract available.

7

Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care.

Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC. Kornblith AB, et al. Among authors: scher hi. Cancer. 1994 Jun 1;73(11):2791-802. doi: 10.1002/1097-0142(19940601)73:11<2791::aid-cncr2820731123>3.0.co;2-9. Cancer. 1994. PMID: 8194021

8

Incorporating tumor biology into therapy for prostate cancer.

Bromberg J, Scher HI. Bromberg J, et al. Among authors: scher hi. Curr Opin Oncol. 1993 May;5(3):546-58. doi: 10.1097/00001622-199305000-00017. Curr Opin Oncol. 1993. PMID: 8494915 Review.

9

Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.

Albanell J, Han W, Mellado B, Gunawardane R, Scher HI, Dmitrovsky E, Moore MA. Albanell J, et al. Among authors: scher hi. Cancer Res. 1996 Apr 1;56(7):1503-8. Cancer Res. 1996. PMID: 8603393

10

Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145.

Peng D, Fan Z, Lu Y, DeBlasio T, Scher H, Mendelsohn J. Peng D, et al. Cancer Res. 1996 Aug 15;56(16):3666-9. Cancer Res. 1996. PMID: 8706005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters